Increase – Talk Bio

Actionable Insights Powered by AI

Eli Lilly Acquires Organovo’s FXR Program for $10M, Triggering 244% Stock Surge

2 months ago talkbio0Tagged Acquisition, Eli, Eli Lilly, FXR314, Increase, Inflammatory Bowel Diseases, NR1H4 gene, Organovo, Prices, Programs - Publication Format

Eli Lilly, Organovo, FXR program, FXR314, acquisition, inflammatory bowel disease (IBD), stock price increase

AnaptysBio’s Rosnilimab Shows Promising Results in Phase 2b Rheumatoid Arthritis Trial, Driving Stock Surge

2 months ago talkbio0Tagged AnaptysBio, Immunology, Increase, Prices, RENOIR, Rheumatoid Arthritis, Rosnilimab, Treatment Effectiveness

AnaptysBio, rosnilimab, rheumatoid arthritis, Phase 2b trial, RENOIR study, clinical efficacy, stock price increase, immunology therapeutics

Eli Lilly Announces $15 Billion Share Buyback Plan and 15% Dividend Increase

4 months ago talkbio0Tagged dividend, Drug Industry, Eli, Eli Lilly, Increase, Market, Share Buyback

Eli Lilly, Share Buyback, Dividend Increase, Pharmaceutical Industry, Stock Market

Johnson & Johnson Boosts Talc Settlement by $1.1 Billion Amid Ongoing Negotiations

8 months ago talkbio0Tagged Bankruptcy, Increase, Infantile Neuroaxonal Dystrophy, Johnson and Johnson, Talc Settlement

Johnson & Johnson, Talc Settlement, $1.1 Billion Increase, Cancer Lawsuits, Bankruptcy Plan